Health Condition 1: L271- Localized skin eruption due to drugs and medicaments taken internally
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Malignant tumour diagnosed by evidence of pathological or cytological findings An Eastern Cooperative Oncology Group performance status Treatment with Multi Kinase Inhibitors and occurrence of hand-foot skin reaction of any grade. Life expectancy >3 months. Those who are willing to participate in this study and sign informed consent forms.
Exclusion criteria
Exclusion criteria: Dermatological toxicities not induced by Multi Kinase Inhibitors. Concurrent acne vulgaris, eczema, psoriasis and other skin diseases. Abnormal cognition and speech causing difficulty in comprehension, expression and informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the grade of HFSR based on CTCAE v5.0Timepoint: Before intervention : day 0 After intervention : day 31 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in severity of pain according to VAS scale 2. Change in quality of life according to HFQoL questionnaire.Timepoint: Before intervention : day 0 After intervention : day 31 | — |
Countries
India
Contacts
Amrita School of Ayurveda